872 related articles for article (PubMed ID: 12048687)
21. Xp21 dystrophin and 6q dystrophin-related protein. Comparative immunolocalization using multiple antibodies.
Voit T; Haas K; Léger JO; Pons F; Léger JJ
Am J Pathol; 1991 Nov; 139(5):969-76. PubMed ID: 1951635
[TBL] [Abstract][Full Text] [Related]
22. Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens.
Taylor LE; Kaminoh YJ; Rodesch CK; Flanigan KM
Neuropathol Appl Neurobiol; 2012 Oct; 38(6):591-601. PubMed ID: 22243335
[TBL] [Abstract][Full Text] [Related]
23. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
[TBL] [Abstract][Full Text] [Related]
24. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.
Suriyonplengsaeng C; Dejthevaporn C; Khongkhatithum C; Sanpapant S; Tubthong N; Pinpradap K; Srinark N; Waisayarat J
Diagn Pathol; 2017 Feb; 12(1):19. PubMed ID: 28219397
[TBL] [Abstract][Full Text] [Related]
26. PGD for dystrophin gene deletions using fluorescence in situ hybridization.
Malmgren H; White I; Johansson S; Levkov L; Iwarsson E; Fridström M; Blennow E
Mol Hum Reprod; 2006 May; 12(5):353-6. PubMed ID: 16608904
[TBL] [Abstract][Full Text] [Related]
27. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
[TBL] [Abstract][Full Text] [Related]
28. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
Pradhan S
Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical staining of dystrophin on formalin-fixed paraffin-embedded sections in Duchenne/Becker muscular dystrophy and manifesting carriers of Duchenne muscular dystrophy.
Hoshino S; Ohkoshi N; Watanabe M; Shoji S
Neuromuscul Disord; 2000 Aug; 10(6):425-9. PubMed ID: 10899449
[TBL] [Abstract][Full Text] [Related]
30. ELISA quantitation of dystrophin for the diagnosis of Duchenne and Becker muscular dystrophies.
Byers TJ; Neumann PE; Beggs AH; Kunkel LM
Neurology; 1992 Mar; 42(3 Pt 1):570-6. PubMed ID: 1549217
[TBL] [Abstract][Full Text] [Related]
31. The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related.
Taylor J; Muntoni F; Dubowitz V; Sewry CA
Neuropathol Appl Neurobiol; 1997 Oct; 23(5):399-405. PubMed ID: 9364465
[TBL] [Abstract][Full Text] [Related]
32. Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy.
Ito T; Takeshima Y; Yagi M; Kamei S; Wada H; Nakamura H; Matsuo M
J Neurol; 2003 May; 250(5):581-7. PubMed ID: 12736738
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of skin biopsy in dystrophinopathies.
Tanveer N; Sharma MC; Sarkar C; Gulati S; Kalra V; Singh S; Bhatia R
Clin Neurol Neurosurg; 2009 Jul; 111(6):496-502. PubMed ID: 19251360
[TBL] [Abstract][Full Text] [Related]
34. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells.
Skuk D; Goulet M; Roy B; Chapdelaine P; Bouchard JP; Roy R; Dugré FJ; Sylvain M; Lachance JG; Deschênes L; Senay H; Tremblay JP
J Neuropathol Exp Neurol; 2006 Apr; 65(4):371-86. PubMed ID: 16691118
[TBL] [Abstract][Full Text] [Related]
35. Analysis of dystrophin in muscular diseases by two-dimensional gel electrophoresis using agarose gels in the first dimension.
Hamano K; Takeya T; Iwasaki N; Okoshi N; Fukubayashi T; Kirinoki M; Yao Y; Hirabayashi T; Takita H
Acta Neurol Belg; 1996 Jun; 96(2):102-7. PubMed ID: 8711982
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of dystrophin positive fibers in Duchenne muscular dystrophy].
Chuang YH; Jong YJ; Liu KM; Chen SS
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):409-15. PubMed ID: 7650780
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
38. [Study of dystrophin gene non-deletion/duplication mutations causing Becker muscular dystrophy].
Cao JQ; Zhang C; Feng SW; Yang J; Li Z; Zhang M; Li SY; Sun XF; Wang YY; Zheng MY; Kong J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):308-12. PubMed ID: 21644230
[TBL] [Abstract][Full Text] [Related]
39. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
Yuasa K; Nakamura A; Hijikata T; Takeda S
BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic value of neuronal nitric oxide synthase antibody for clinically suspected Becker muscular dystrophy].
Li XH; Zhao L; Wu Y; Wu J; He DK; Liu XQ
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Apr; 13(4):288-91. PubMed ID: 21507296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
